Jon M. Foster - 13 Feb 2025 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: EVP and COO
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 13 Feb 2025
Net transactions value: -$220,193
Form type: 4
Filing time: 18 Feb 2025, 19:33:00 UTC
Previous filing: 30 Jan 2025
Next filing: 15 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+2,750	+10%	$0.000000	29,028	13 Feb 2025	Direct	F1
transaction	HCA	Common Stock	Tax liability	$220,193	-684	-2.4%	$321.92	28,344	13 Feb 2025	Direct
holding	HCA	Common Stock						66,515	13 Feb 2025	By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
holding	HCA	Common Stock						54,308	13 Feb 2025	By LCF Trust (Reporting Person, Trustee)
holding	HCA	Common Stock						18,000	13 Feb 2025	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 28, 2022, the reporting person was granted 5,300 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

Content

On January 28, 2022, the reporting person was granted 5,300 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.